Literature DB >> 3487362

In situ quantification of T-cell subsets, NK-like cells and macrophages in Hodgkin's disease: quantity and quality of infiltration density depends on histopathological subtypes.

G Gattringer, R Greil, T Radaszkiewicz, H Huber.   

Abstract

The present investigation addressed itself to the in situ quantification of reactive cells in tumour tissues affected by Hodgkin's disease. Immunostaining was used for identification and stereology was used for enumeration of T-helper/inducer (CD4+) T-cytotoxic/suppressor (CD8+), NK-like (Leu7+) and cells of macrophage origin (Mono 2+). The evaluation of 50 cases showed that CD4+ cells always outnumbered CD8+ cells but the degree of this predominance varied depending on the histopathological subtypes (n.s. greater than m.c. greater than l.d.). Lymph nodes contained more CD4+ as well as CD8+ cells compared to spleens. Therefore, no changes in the T4:T8 ratio occurred. No significant differences in the densities of NK-like cells were observed, comparing the different histopathological subtypes as well as lymph nodes and spleens. Similarly, macrophage (M phi) density was comparable in all histopathological subtypes. However, lymph nodes contained significantly more M phi compared to spleens. On comparison of reactive cells in Hodgkin's tissues to non-Hodgkin lymphomas (79 cases) and normal controls (7 cases) significantly higher numbers of CD4+, CD8+ and Mono 2+ cells were found in Hodgkin's compared to non-Hodgkin's lymphomas. In contrast, the density of NK-like cells in NHL as well as in normal tissues was fivefold compared to that observed in Hodgkin's tissues.

Entities:  

Mesh:

Year:  1986        PMID: 3487362     DOI: 10.1007/BF00320582

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  26 in total

1.  Natural killer activity in spleens and lymph nodes from patients with Hodgkin's disease.

Authors:  L P Ruco; A Procopio; S Uccini; E Marcorelli; C D Baroni
Journal:  Cancer Res       Date:  1982-05       Impact factor: 12.701

2.  An immunohistological study of the cellular constituents of Hodgkin's disease using a monoclonal antibody panel.

Authors:  Z Abdulaziz; D Y Mason; H Stein; K C Gatter; J R Nash
Journal:  Histopathology       Date:  1984-01       Impact factor: 5.087

3.  Tissue T-lymphocytes in untreated Hodgkin's disease: morphologic and functional correlations in spleens and lymph nodes.

Authors:  C D Baroni; L Ruco; S Uccini; A Foschi; M Occhionero; E Marcorelli
Journal:  Cancer       Date:  1982-07-15       Impact factor: 6.860

4.  Clonal analysis of human cytotoxic T lymphocytes: T4+ and T8+ effector T cells recognize products of different major histocompatibility complex regions.

Authors:  S C Meuer; S F Schlossman; E L Reinherz
Journal:  Proc Natl Acad Sci U S A       Date:  1982-07       Impact factor: 11.205

5.  Immunohistologic localization and immune phenotypes of lymphocytes expressing Tac antigen in human lymphoid tissues.

Authors:  T Miyawaki; S Ohzeki; N Ikuta; H Seki; K Taga; N Taniguchi
Journal:  J Immunol       Date:  1984-12       Impact factor: 5.422

6.  Infiltration density of HNK 1 positive cells in non-Hodgkin's lymphomas depends on histologic subtype: an in situ morphometric analysis.

Authors:  C Gattringer; T Radaszkiewicz; W Pfaller; H Huber
Journal:  Immunobiology       Date:  1985-04       Impact factor: 3.144

7.  In situ immunologic characterization of cellular constituents in lymph nodes and spleens involved by Hodgkin's disease.

Authors:  S Poppema; A K Bhan; E L Reinherz; M R Posner; S F Schlossman
Journal:  Blood       Date:  1982-02       Impact factor: 22.113

8.  Immunohistological analysis of Tac antigen expression in tissues involved by Hodgkin's disease.

Authors:  G Pizzolo; M Chilosi; G Semenzato; F Caligaris-Cappio; L Fiore-Donati; G Perona; G Janossy
Journal:  Br J Cancer       Date:  1984-09       Impact factor: 7.640

9.  Characteristics of Sternberg-Reed, and related cells in Hodgkin's disease: an immunohistological study.

Authors:  M S Dorreen; J A Habeshaw; A G Stansfeld; P F Wrigley; T A Lister
Journal:  Br J Cancer       Date:  1984-04       Impact factor: 7.640

10.  Mononuclear-cell infiltration in ovarian cancer. I. Inflammatory-cell infiltrates from tumour and ascites material.

Authors:  S Haskill; S Becker; W Fowler; L Walton
Journal:  Br J Cancer       Date:  1982-05       Impact factor: 7.640

View more
  7 in total

1.  Hodgkin lymphoma: flow me?

Authors:  Michael W Beaty; Kim R Geisinger
Journal:  Cytojournal       Date:  2005-09-08       Impact factor: 2.091

Review 2.  Acquired Natural Killer Cell Dysfunction in the Tumor Microenvironment of Classic Hodgkin Lymphoma.

Authors:  Jodi Chiu; Daniel M Ernst; Armand Keating
Journal:  Front Immunol       Date:  2018-02-14       Impact factor: 7.561

Review 3.  Heat Shock Proteins in Lymphoma Immunotherapy.

Authors:  Zarema Albakova; Yana Mangasarova; Alexander Sapozhnikov
Journal:  Front Immunol       Date:  2021-03-18       Impact factor: 7.561

Review 4.  Microenvironment Cell Contribution to Lymphoma Immunity.

Authors:  Deepika Kumar; Mina L Xu
Journal:  Front Oncol       Date:  2018-07-27       Impact factor: 6.244

5.  Humanized anti-CD123 antibody facilitates NK cell antibody-dependent cell-mediated cytotoxicity (ADCC) of Hodgkin lymphoma targets via ARF6/PLD-1.

Authors:  Daniel Ernst; Brent A Williams; Xing-Hua Wang; Nara Yoon; Kyung-Phil Kim; Jodi Chiu; Zhi Juan Luo; Karin G Hermans; Joerg Krueger; Armand Keating
Journal:  Blood Cancer J       Date:  2019-01-15       Impact factor: 11.037

6.  Reduced frequency of cytotoxic CD56dim CD16+ NK cells leads to impaired antibody-dependent degranulation in EBV-positive classical Hodgkin lymphoma.

Authors:  Elena Pánisová; Anna Lünemann; Simone Bürgler; Monika Kotur; Julien Lazarovici; Alina Danu; Meike Kaulfuss; Juliane Mietz; Obinna Chijioke; Christian Münz; Pierre Busson; Christoph Berger; David Ghez; Tarik Azzi
Journal:  Cancer Immunol Immunother       Date:  2021-05-15       Impact factor: 6.968

Review 7.  Tumor Immune Microenvironment in Lymphoma: Focus on Epigenetics.

Authors:  Daniel J García-Domínguez; Lourdes Hontecillas-Prieto; Natalia Palazón-Carrión; Carlos Jiménez-Cortegana; Víctor Sánchez-Margalet; Luis de la Cruz-Merino
Journal:  Cancers (Basel)       Date:  2022-03-13       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.